Use the Back button in your browser to see the other results of your search or to select another record.
Effects of Otago Exercise Program on serum Interleukin-6 level in older women [with consumer summary] |
Gde Agung Mahendra ID, Subadi I, Wardhani IL, Satyawati R, Alit Pawana IP, Melaniani S |
Annals of Medicine and Surgery 2022 Jun;78:103733 |
clinical trial |
4/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: Otago Exercise Program (OEP) has been demonstrated to minimize the risk of falling in older adults by improving muscular strength and balance. Meanwhile, reduced IL-6 level serves as a biomarker of regular physical activity. OBJECTIVE: Analyzing OEP effect on decreased IL-6 level in elderly women. METHODS: This study used a randomized control trial design from October 2020 to May 2021. 26 participants were divided into a treatment group (13 participants) and a control group (13 participants). The treatment group received OEP for 8 weeks, in which the OEP was carried out 3 times during the first week. On the other hand, the control group did not get intervention. The IL-6 level was measured 2 times, before and after OEP. The measurement results were analyzed using paired t-test and independent t-test, which were declared significant if p < 0.05. RESULTS: The participants' average IL-6 level at pretest and posttest was 4.77 +/- 1.71 pg/mL and 4.57 +/- 1.74 pg/mL, respectively. The IL-16 level of the treatment group at pretest and posttest was 4.22 +/- 1.72 pg/mL and 3.97 +/- 1.67 pg/mL, respectively (t = 1.058; 95% CI -0.770 -0.267; p = 0.311). Meanwhile, the IL-6 level of the control group at pretest and posttest was 5.30 +/- 1.59 pg/mL and 5.16 +/- 1.65 pg/mL, respectively (t = 0.382; 95% CI -0.969 -0.680; p = 0.709). The DELTAIL-6 level in the treatment and control group was -0.25 +/- 0.85 pg/mL and -0.14 +/- 1.36 pg/mL, respectively (t = 0.240; 95% CI -1.030 -0.815; p = 0.813). CONCLUSION: The OEP didn't lower serum IL-6 levels after eight weeks.
|